首页> 外文期刊>Therapeutic Drug Monitoring >Suitability of the DRI Hydrocodone/Hydromorphone Immunoassay in the Clinical Environment at a Lower Cutoff: Validation With LC-MS/MS Analysis
【24h】

Suitability of the DRI Hydrocodone/Hydromorphone Immunoassay in the Clinical Environment at a Lower Cutoff: Validation With LC-MS/MS Analysis

机译:DRI氢可酮/氢吗啡酮免疫分析法在较低临界值下在临床环境中的适用性:LC-MS / MS分析的验证

获取原文
获取原文并翻译 | 示例
           

摘要

Background: We evaluated the analytical performance of the DRI hydrocodone/hydromorphone assay by comparing semi-quantitative values obtained by this assay with values obtained by a liquid chromatography combined with tandem mass spectrometry (LC-MS/MS) method. We also evaluated the possibility of lowering the cutoff of the DRI assay from 300 to 100 ng/mL.
机译:背景:我们通过比较此测定法获得的半定量值与液相色谱-串联质谱法(LC-MS / MS)获得的值,评估了DRI氢可酮/氢吗啡酮测定的分析性能。我们还评估了将DRI分析的临界值从300 ng / mL降低到100 ng / mL的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号